Glenmark Life Sciences Limited Current Assets

As of the most recent data (March 2026), GLS.BO shows a current assets of $26B. That compares with $23B in the prior-year period — up 13.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GLS.BO's current assets is now $26B (was $23B) — a 13.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Glenmark Life Sciences Limited is outperforming or lagging.

Tracking GLS.BO's current assets over time shows whether Glenmark Life Sciences Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $26B That compares with $23B in the prior-year period — up 13.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Glenmark Life Sciences Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $26B) with ownership activity and broader fundamentals.